313 related articles for article (PubMed ID: 28855269)
41. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.
Salehi M; Prigeon RL; D'Alessio DA
Diabetes; 2011 Sep; 60(9):2308-14. PubMed ID: 21868791
[TBL] [Abstract][Full Text] [Related]
42. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?
Dar MS; Chapman WH; Pender JR; Drake AJ; O'Brien K; Tanenberg RJ; Dohm GL; Pories WJ
Obes Surg; 2012 Jul; 22(7):1077-83. PubMed ID: 22419108
[TBL] [Abstract][Full Text] [Related]
43. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
[TBL] [Abstract][Full Text] [Related]
44. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Nielsen S; Svane MS; Kuhre RE; Clausen TR; Kristiansen VB; Rehfeld JF; Holst JJ; Madsbad S; Bojsen-Moller KN
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28202805
[TBL] [Abstract][Full Text] [Related]
45. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
46. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
47. Marked improvement of insulin sensitivity without enhancement of GLP-1 and insulin secretion after Roux-en-Y gastric bypass surgery in a mildly obese patient with diabetes.
Yamashita K; Sato Y; Oki K; Kishimoto H; Yamauchi K; Aizawa T
Horm Metab Res; 2014 Jun; 46(6):424-6. PubMed ID: 24526371
[TBL] [Abstract][Full Text] [Related]
48. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
[TBL] [Abstract][Full Text] [Related]
49. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
[TBL] [Abstract][Full Text] [Related]
50. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
51. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.
Plum L; Ahmed L; Febres G; Bessler M; Inabnet W; Kunreuther E; McMahon DJ; Korner J
Obesity (Silver Spring); 2011 Nov; 19(11):2149-57. PubMed ID: 21593800
[TBL] [Abstract][Full Text] [Related]
52. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.
Salehi M; D'Alessio DA
Surg Obes Relat Dis; 2016 Jul; 12(6):1230-5. PubMed ID: 27568473
[TBL] [Abstract][Full Text] [Related]
54. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
[TBL] [Abstract][Full Text] [Related]
55. Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.
Alexiadou K; Cuenco J; Howard J; Wewer Albrechtsen NJ; Ilesanmi I; Kamocka A; Tharakan G; Behary P; Bech PR; Ahmed AR; Purkayastha S; Wheller R; Fleuret M; Holst JJ; Bloom SR; Khoo B; Tan TM
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32209584
[TBL] [Abstract][Full Text] [Related]
56. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
[TBL] [Abstract][Full Text] [Related]
57. Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M
Diabetes Obes Metab; 2024 Jun; 26(6):2476-2486. PubMed ID: 38558527
[TBL] [Abstract][Full Text] [Related]
58. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
[TBL] [Abstract][Full Text] [Related]
59. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass.
Cui Y; Elahi D; Andersen DK
J Gastrointest Surg; 2011 Oct; 15(10):1879-88. PubMed ID: 21671112
[TBL] [Abstract][Full Text] [Related]
60. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
